{
    "nct_id": "NCT03335540",
    "official_title": "ADaptiVe Biomarker Trial That InformS Evolution of Therapy",
    "inclusion_criteria": "* Participants must have an ECOG performance status of less than or equal to 1\n* Participants must have had prior therapy;Participants who have received adjuvant or neoadjuvant anti-PD(L)1 therapy andprogressed within 6 months of completing therapy will be considered IO refractory.\n* Participants must have at least 2 lesions with measurable disease as defined by RECIST Version 1.1\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Participants with suspected, known, or progressive CNS metastases, have untreated CNS metastases, or have the CNS as the only site of disease\n* Participants with carcinomatous meningitis\n* Participants with other active malignancy requiring concurrent intervention\n\nOther protocol defined inclusion/exclusion criteria could apply",
    "miscellaneous_criteria": ""
}